Hannah Valantine - Net Worth and Insider Trading
Hannah Valantine Net Worth
The estimated net worth of Hannah Valantine is at least $188,677 dollars as of 2025-04-26. Hannah Valantine is the Director of BridgeBio Pharma Inc and owns about 5,197 shares of BridgeBio Pharma Inc (BBIO) stock worth over $188,677. Details can be seen in Hannah Valantine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hannah Valantine has not made any transactions after 2025-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hannah Valantine
Hannah Valantine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hannah Valantine owns 3 companies in total, including CareDx Inc (CDNA) , Pacific Biosciences of California Inc (PACB) , and BridgeBio Pharma Inc (BBIO) .
Click here to see the complete history of Hannah Valantine’s form 4 insider trades.
Insider Ownership Summary of Hannah Valantine
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CDNA | CareDx Inc | 2021-07-01 | director |
| PACB | Pacific Biosciences of California Inc | 2021-06-16 | director |
| BBIO | BridgeBio Pharma Inc | 2025-03-06 | director |
Hannah Valantine Latest Holdings Summary
Hannah Valantine currently owns a total of 1 stock. Hannah Valantine owns 5,197 shares of BridgeBio Pharma Inc (BBIO) as of March 6, 2025, with a value of $188,677.
Latest Holdings of Hannah Valantine
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma Inc | 2025-03-06 | 5,197 | 36.31 | 188,677 |
Holding Weightings of Hannah Valantine
Hannah Valantine Form 4 Trading Tracker
According to the SEC Form 4 filings, Hannah Valantine has made a total of 5 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 12,875 shares on March 6, 2025, which brought Hannah Valantine around $419,468.
Insider Trading History of Hannah Valantine
- 1
Hannah Valantine Trading Performance
GuruFocus tracks the stock performance after each of Hannah Valantine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hannah Valantine is -23.47%. GuruFocus also compares Hannah Valantine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hannah Valantine within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hannah Valantine's insider trading performs compared to the benchmark.
Performance of Hannah Valantine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -36.29 | | | | | |
| Relative Return to S&P 500(%) | -28.75 | | | | | |
Hannah Valantine Ownership Network
Ownership Network List of Hannah Valantine
Ownership Network Relation of Hannah Valantine
Hannah Valantine Owned Company Details
What does CareDx Inc do?
Who are the key executives at CareDx Inc?
Hannah Valantine is the director of CareDx Inc. Other key executives at CareDx Inc include See Remarks Abhishek Jain , director & President and CEO Peter Maag , and Chief Business Officer Alexander L Johnson .
CareDx Inc (CDNA) Insider Trades Summary
Over the past 18 months, Hannah Valantine made no insider transaction in CareDx Inc (CDNA). Other recent insider transactions involving CareDx Inc (CDNA) include a net sale of 13,110 shares made by , a net sale of 95,254 shares made by Alexander L Johnson , and a net sale of 40,552 shares made by Peter Maag .
In summary, during the past 3 months, insiders sold 24,701 shares of CareDx Inc (CDNA) in total and bought 0 shares, with a net sale of 24,701 shares. During the past 18 months, 169,181 shares of CareDx Inc (CDNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 169,181 shares.
CareDx Inc (CDNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
CareDx Inc Insider Transactions
Hannah Valantine Mailing Address
Above is the net worth, insider trading, and ownership report for Hannah Valantine. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Hannah Valantine's mailing address is: Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
